1. Home
  2. Clinical Topics
  3. FDA permits marketing of new device for treating diabetic foot ulcers
Clinical TopicsDrugs and DevicesWeb Exclusives
fda foot ulcer device diabetic

FDA permits marketing of new device for treating diabetic foot ulcers

Share

On December 28, 2017, the U.S. Food and Drug Administration (FDA) permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.

Read more via Fda.gov.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts